Targeting integrin/CD49D/VLA-4 with natalizumab can inhibit adhesion of malignant B cells and sensitize them to chemoimmunotherapy
Authors | |
---|---|
Year of publication | 2010 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |
Go to main content | Go to main menu | Go to search
Authors |
MRÁZ Marek ZENT C. CHURCH A. JELINEK D. POSPÍŠILOVÁ Šárka ANSELL S. NOVAK A. WITZIG T. NOWAKOWSKI G. |
---|---|
Year of publication | 2010 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |